Literature DB >> 31977298

Contributions of Eosinophils to Human Health and Disease.

Amy D Klion1, Steven J Ackerman2, Bruce S Bochner3.   

Abstract

The human eosinophil has long been thought to favorably influence innate mucosal immunity but at times has also been incriminated in disease pathophysiology. Research into eosinophil biology has uncovered a number of interesting contributions by eosinophils to health and disease. However, it appears that not all eosinophils from all species are created equal. It remains unclear, for example, exactly how having eosinophils benefits the human host when helminth infections in the developed world have become scarce. This review focuses on our current state of knowledge as it relates to human eosinophils. When information is lacking, we discuss lessons learned from mouse studies that may or may not directly apply to human biology and disease. It is an exciting time to be an "eosinophilosopher" because the use of biologic agents that selectively target eosinophils provides an unprecedented opportunity to define the contribution of this cell to eosinophil-associated human diseases.

Entities:  

Keywords:  biologic agents; biomarkers; cytokines; eosinophil; eosinophil-related diseases; function; hematopoiesis; hypereosinophilic syndrome; phenotype; treatments

Mesh:

Year:  2020        PMID: 31977298      PMCID: PMC7604902          DOI: 10.1146/annurev-pathmechdis-012419-032756

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  138 in total

1.  Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants.

Authors:  Keir M Balla; Geanncarlo Lugo-Villarino; Jan M Spitsbergen; David L Stachura; Yan Hu; Karina Bañuelos; Octavio Romo-Fewell; Raffi V Aroian; David Traver
Journal:  Blood       Date:  2010-08-16       Impact factor: 22.113

2.  Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.

Authors:  Evan S Dellon; Spencer Rusin; Jessica H Gebhart; Shannon Covey; Leana L Higgins; RoseMary Beitia; Olga Speck; Kimberly Woodward; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2015-03-17       Impact factor: 10.864

Review 3.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

4.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

5.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Authors:  Marc E Rothenberg; Amy D Klion; Florence E Roufosse; Jean Emmanuel Kahn; Peter F Weller; Hans-Uwe Simon; Lawrence B Schwartz; Lanny J Rosenwasser; Johannes Ring; Elaine F Griffin; Ann E Haig; Paul I H Frewer; Jacqueline M Parkin; Gerald J Gleich
Journal:  N Engl J Med       Date:  2008-03-16       Impact factor: 91.245

6.  Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine.

Authors:  G M Kephart; G J Gleich; D H Connor; D W Gibson; S J Ackerman
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

7.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

Authors:  M Kopf; F Brombacher; P D Hodgkin; A J Ramsay; E A Milbourne; W J Dai; K S Ovington; C A Behm; G Köhler; I G Young; K I Matthaei
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

8.  Eosinophils may play regionally disparate roles in influencing IgA(+) plasma cell numbers during large and small intestinal inflammation.

Authors:  Ruth Forman; Michael Bramhall; Larisa Logunova; Marcus Svensson-Frej; Sheena M Cruickshank; Kathryn J Else
Journal:  BMC Immunol       Date:  2016-05-31       Impact factor: 3.615

Review 9.  Homeostatic Eosinophils: Characteristics and Functions.

Authors:  Thomas Marichal; Claire Mesnil; Fabrice Bureau
Journal:  Front Med (Lausanne)       Date:  2017-07-11

10.  CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils.

Authors:  Nina K Serwas; Jakob Huemer; Régis Dieckmann; Ester Mejstrikova; Wojciech Garncarz; Jiri Litzman; Birgit Hoeger; Ondrej Zapletal; Ales Janda; Keiryn L Bennett; Renate Kain; Dontscho Kerjaschky; Kaan Boztug
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

View more
  37 in total

1.  Influenza A virus directly modulates mouse eosinophil responses.

Authors:  Kim S LeMessurier; Robert Rooney; Hazem E Ghoneim; Baoming Liu; Kui Li; Heather S Smallwood; Amali E Samarasinghe
Journal:  J Leukoc Biol       Date:  2020-05-09       Impact factor: 4.962

2.  An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.

Authors:  Michael M Chen; Florence Roufosse; Sa A Wang; Srdan Verstovsek; Sandy R Durrani; Marc E Rothenberg; Thanai Pongdee; Joseph Butterfield; Timothy Lax; Michael E Wechsler; Miguel L Stein; Princess U Ogbogu; Basil M Kahwash; Sameer K Mathur; Dagmar Simon; Praveen Akuthota; Nicole Holland; Lauren Wetzler; JeanAnne M Ware; Canting Guo; Michael P Fay; Paneez Khoury; Amy D Klion; Bruce S Bochner
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

Review 3.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

4.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

Review 5.  Lessons learned from targeting eosinophils in human disease.

Authors:  Fei Li Kuang; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-04-23       Impact factor: 11.759

6.  Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.

Authors:  Mineyo Fukuchi; Yosuke Kamide; Shigeharu Ueki; Yui Miyabe; Yasunori Konno; Nobuyuki Oka; Hiroki Takeuchi; Souichi Koyota; Makoto Hirokawa; Takechiyo Yamada; Rossana C N Melo; Peter F Weller; Masami Taniguchi
Journal:  Arthritis Rheumatol       Date:  2021-08-11       Impact factor: 15.483

Review 7.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

Review 8.  Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy.

Authors:  Despina Michailidou; Daniella Muallem Schwartz; Tomas Mustelin; Grant C Hughes
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

9.  A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma.

Authors:  Dave Singh; Rainard Fuhr; Nicholas P Bird; Sarah Mole; Kelly Hardes; Yau Lun Man; Anthony Cahn; Steven W Yancey; Isabelle J Pouliquen
Journal:  Br J Clin Pharmacol       Date:  2021-08-24       Impact factor: 3.716

Review 10.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.